A survey on computational methods in discovering protein inhibitors of SARS-CoV-2.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34623382.
- Also identified by DOI 10.1093/bib/bbab416 and PMC identifier 8524468.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The outbreak of acute respiratory disease in 2019, namely Coronavirus Disease-2019 (COVID-19), has become an unprecedented healthcare crisis. To mitigate the pandemic, there are a lot of collective and multidisciplinary efforts in facilitating the rapid discovery of protein inhibitors or drugs against COVID-19. Although many computational methods to predict protein inhibitors have been developed [ 1- 5], few systematic reviews on these methods have been published. Here, we provide a comprehensive overview of the existing methods to discover potential inhibitors of COVID-19 virus, so-called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). First, we briefly categorize and describe computational approaches by the basic algorithms involved in. Then we review the related biological datasets used in such predictions. Furthermore, we emphatically discuss current knowledge on SARS-CoV-2 inhibitors with the latest findings and development of computational methods in uncovering protein inhibitors against COVID-19.
Medical subject headings
- Antiviral Agents
- COVID-19
- Computational Biology
- Molecular Docking Simulation
- Pandemics
- SARS-CoV-2
- COVID-19 Drug Treatment